CAMP
Camp4 Therapeutics Corp
NASDAQ · Healthcare · Biotechnology · US
$4.24
+5.21%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 29.41x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -383.94x
- Price / sales
- 63.11x
- Price / cash flow
- -9.31x
Enterprise value
- Enterprise value
- $181.3M
- EV / sales
- 43.01x
- EV / EBITDA
- -2.48x
- EV / EBIT
- -3.46x
- Market cap
- $266.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026